Amylyx Pharmaceuticals

Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail
BioSpace
Thu, 04/4/24 - 11:25 am
Amylyx Pharmaceuticals
ALS
Relyvrio
Amylyx’s ALS drug knocked back again in Europe
BioPharma Dive
Fri, 10/13/23 - 11:59 am
Amylyx Pharmaceuticals
ALS
Europe
EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's ALS Treatment
Benzinga
Fri, 06/23/23 - 09:51 am
Amylyx Pharmaceuticals
ALS
Albrioza
EMA
Europe
Amylyx’s ALS drug Relyvrio generates $71.4M in Q1
Medical Marketing and Media
Mon, 05/15/23 - 10:14 am
Amylyx Pharmaceuticals
ALS
earnings
Relyvrio
Amylyx counters Wall Street noise, cites demand for ALS drug
Medical Marketing and Media
Wed, 02/15/23 - 10:39 am
Amylyx Pharmaceuticals
Relyvrio
ALS
Cigna restricts coverage of new ALS drug, deepening fears about access
BioPharma Dive
Wed, 02/8/23 - 10:48 am
Amylyx Pharmaceuticals
ALS
Relyvrio
insurers
Cigna
Days after Relyvrio’s FDA approval, Amylyx announces public offering to fund effort
Medical Marketing and Media
Wed, 10/5/22 - 07:13 pm
Amylyx Pharmaceuticals
ALS
Relyvrio
stock offering
ALS drug's approval draws cheers from patients, questions from skeptics
NPR
Sun, 10/2/22 - 07:45 pm
ALS
FDA
Amylyx Pharmaceuticals
drug pricing
Relyvrio
FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
Stat
Thu, 09/29/22 - 07:44 pm
Amylyx Pharmaceuticals
ALS
Relyvrio
FDA
Looming Amylyx drug approval decision renews debate over ALS endpoints
Clinical Trials Arena
Thu, 09/15/22 - 10:35 am
Amylyx Pharmaceuticals
AMX-0035
ALS
clinical trials
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
Amylyx gets first approval for ALS drug from Canada
Yahoo/Reuters
Mon, 06/13/22 - 10:42 am
Amylyx Pharmaceuticals
ALS
Canada
Albrioza
Biopharma flotations tank in the first quarter
EP Vantage
Thu, 04/7/22 - 10:11 am
Amylyx Pharmaceuticals
CinCor Pharma
Arcellx
Vigil Neuroscience
AN2 Therapeutics
IPOs
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Amylyx asks FDA to approve ALS drug, while also preparing late-stage study
BioPharma Dive
Tue, 11/2/21 - 10:58 am
Amylyx Pharmaceuticals
AMX-0035
FDA
ALS
After talks with FDA, a biotech prepares to submit its closely watched ALS drug
BioPharma Dive
Wed, 09/15/21 - 10:48 am
Amylyx Pharmaceuticals
FDA
ALS
AMX-0035
Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion
BioPharma Dive
Tue, 07/20/21 - 12:31 pm
Amylyx Pharmaceuticals
ALS
venture capital
FDA
AMX0035
FDA faces backlash after seeking more data on an experimental ALS therapy
BioPharma Dive
Wed, 04/14/21 - 09:53 pm
ALS
AMX0035
Amylyx Pharmaceuticals
FDA
Early signs of survival benefit raise optimism around a small biotech's ALS drug
BioPharma Dive
Sun, 10/18/20 - 12:03 am
ALS
AMX0035
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals nabs $30M for ALS, Alzheimer's work
Fierce Biotech
Thu, 07/2/20 - 11:11 am
Amylyx Pharmaceuticals
funding
ALS
Alzheimer's disease

Pages